MRPS27
gene geneOn this page
Also known as KIAA0264mS27
Summary
MRPS27 (mitochondrial ribosomal protein S27, HGNC:14512) is a protein-coding gene on chromosome 5q13.2, encoding Small ribosomal subunit protein mS27 (Q92552). RNA-binding component of the mitochondrial small ribosomal subunit (mt-SSU) that plays a role in mitochondrial protein synthesis. It is a selective cancer dependency (DepMap: 50.5% of cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 28S subunit protein that may be a functional partner of the death associated protein 3 (DAP3). Alternative splicing results in multiple transcript variants encoding different isoforms.
Source: NCBI Gene 23107 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 82 total
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 50.5% of screened cell lines
- MANE Select transcript:
NM_015084
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14512 |
| Approved symbol | MRPS27 |
| Name | mitochondrial ribosomal protein S27 |
| Location | 5q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA0264, mS27 |
| Ensembl gene | ENSG00000113048 |
| Ensembl biotype | protein_coding |
| OMIM | 611989 |
| Entrez | 23107 |
Gene structure
Transcript identifiers
Ensembl transcripts: 34 — 19 protein_coding, 8 protein_coding_CDS_not_defined, 4 nonsense_mediated_decay, 3 retained_intron
ENST00000261413, ENST00000457646, ENST00000506957, ENST00000508863, ENST00000513900, ENST00000515226, ENST00000515404, ENST00000519143, ENST00000519874, ENST00000520285, ENST00000522042, ENST00000522095, ENST00000522404, ENST00000522562, ENST00000522585, ENST00000523654, ENST00000694989, ENST00000694990, ENST00000694991, ENST00000694992, ENST00000694993, ENST00000694994, ENST00000694995, ENST00000694996, ENST00000694997, ENST00000694998, ENST00000695000, ENST00000695001, ENST00000695297, ENST00000695298, ENST00000695403, ENST00000695404, ENST00000926538, ENST00000953797
RefSeq mRNA: 3 — MANE Select: NM_015084
NM_001286748, NM_001286751, NM_015084
CCDS: CCDS4013, CCDS68890, CCDS75257
Canonical transcript exons
ENST00000261413 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001927754 | 72320149 | 72320240 |
| ENSE00003492613 | 72297632 | 72297702 |
| ENSE00003494554 | 72223683 | 72223850 |
| ENSE00003507460 | 72234119 | 72234197 |
| ENSE00003541754 | 72228266 | 72228368 |
| ENSE00003579025 | 72226057 | 72226199 |
| ENSE00003591434 | 72238014 | 72238128 |
| ENSE00003592952 | 72295531 | 72295589 |
| ENSE00003618953 | 72232443 | 72232558 |
| ENSE00003654856 | 72314081 | 72314158 |
| ENSE00003963647 | 72219403 | 72221148 |
Expression profiles
Bgee: expression breadth ubiquitous, 292 present calls, max score 94.44.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 62.2866 / max 1187.4336, expressed in 1814 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 62036 | 59.2501 | 1809 |
| 62035 | 1.7817 | 1054 |
| 62034 | 1.2548 | 716 |
Top tissues by expression
302 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| heart left ventricle | UBERON:0002084 | 94.44 | gold quality |
| cardiac ventricle | UBERON:0002082 | 94.36 | gold quality |
| calcaneal tendon | UBERON:0003701 | 94.36 | gold quality |
| apex of heart | UBERON:0002098 | 94.16 | gold quality |
| muscle of leg | UBERON:0001383 | 94.14 | gold quality |
| gastrocnemius | UBERON:0001388 | 94.09 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.08 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.05 | gold quality |
| heart | UBERON:0000948 | 93.64 | gold quality |
| adrenal tissue | UBERON:0018303 | 93.49 | gold quality |
| cortical plate | UBERON:0005343 | 93.39 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 93.36 | gold quality |
| muscle organ | UBERON:0001630 | 93.35 | gold quality |
| rectum | UBERON:0001052 | 93.34 | gold quality |
| right atrium auricular region | UBERON:0006631 | 93.32 | gold quality |
| cardiac atrium | UBERON:0002081 | 93.28 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.25 | gold quality |
| body of tongue | UBERON:0011876 | 93.20 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 93.18 | gold quality |
| right ovary | UBERON:0002118 | 93.15 | gold quality |
| embryo | UBERON:0000922 | 93.10 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 92.89 | gold quality |
| adrenal cortex | UBERON:0001235 | 92.87 | gold quality |
| adrenal gland | UBERON:0002369 | 92.87 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 92.86 | gold quality |
| left ovary | UBERON:0002119 | 92.85 | gold quality |
| ventricular zone | UBERON:0003053 | 92.83 | gold quality |
| islet of Langerhans | UBERON:0000006 | 92.79 | gold quality |
| ovary | UBERON:0000992 | 92.69 | gold quality |
| mucosa of stomach | UBERON:0001199 | 92.68 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.19 |
| E-ENAD-17 | no | 1013.75 |
| E-CURD-112 | no | 3.70 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): AR
miRNA regulators (miRDB)
60 targeting MRPS27, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-221-5P | 99.86 | 65.45 | 1052 |
| HSA-MIR-8073 | 99.86 | 65.21 | 1118 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-4668-5P | 99.79 | 70.58 | 3782 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-4428 | 99.73 | 66.41 | 1733 |
| HSA-MIR-802 | 99.61 | 67.70 | 1254 |
| HSA-MIR-6716-5P | 99.56 | 68.62 | 1244 |
| HSA-MIR-302B-5P | 99.50 | 69.49 | 1857 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 50.5% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 3)
- MRPS27 is required for mitochondrial protein synthesis (PMID:22841715)
- we verified for the first time that mitochondrial ribosomal protein S23 expression was upregulated in hepatocellular carcinoma. High mitochondrial ribosomal protein S23 levels can predict poor clinical outcomes in hepatocellular carcinoma, and this protein plays a key role in tumor proliferation. Therefore, mitochondrial ribosomal protein S23 may be a potential therapeutic target for hepatocellular carcinoma. (PMID:28714366)
- The value of RPS15 and MRPS27 in ischemic stroke. (PMID:37603533)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mrps27 | ENSDARG00000059234 |
| mus_musculus | Mrps27 | ENSMUSG00000041632 |
| rattus_norvegicus | Mrps27 | ENSRNOG00000017272 |
| drosophila_melanogaster | CG4882 | FBGN0025336 |
| caenorhabditis_elegans | mrps-27 | WBGENE00010766 |
Protein
Protein identifiers
Small ribosomal subunit protein mS27 — Q92552 (reviewed: Q92552)
Alternative names: 28S ribosomal protein S27, mitochondrial, Mitochondrial ribosomal protein S27
All UniProt accessions (16): A0A8Q3SHR4, A0A8Q3WK82, A0A8Q3WK88, A0A8Q3WKF1, A0A8Q3WKH0, A0A8Q3WKI2, A0A8Q3WKI8, A0A8Q3WKM3, A0A8Q3WKS8, Q92552, A0A8Q3WKZ8, A0A8Q3WL16, A0A8Q3WLL6, A0A8Q3WLW2, D6RH20, G5EA06
UniProt curated annotations — full annotation on UniProt →
Function. RNA-binding component of the mitochondrial small ribosomal subunit (mt-SSU) that plays a role in mitochondrial protein synthesis. Stimulates mitochondrial mRNA translation of subunit components of the mitochondrial electron transport chain. Binds to the mitochondrial 12S rRNA (12S mt-rRNA) and tRNA(Glu). Involved also in positive regulation of cell proliferation and tumor cell growth.
Subunit / interactions. Component of the mitochondrial small ribosomal subunit (mt-SSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins. Interacts with NOA1. Interacts with MIEF1 upstream open reading frame protein. Interacts with METTL17.
Subcellular location. Cytoplasm. Mitochondrion.
Tissue specificity. Overexpressed in hepatocellular carcinoma tissues compared with adjacent non-tumoral liver tissues (at protein level). Ubiquitous.
Similarity. Belongs to the mitochondrion-specific ribosomal protein mS27 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q92552-1 | 1 | yes |
| Q92552-2 | 2 |
RefSeq proteins (3): NP_001273677, NP_001273680, NP_055899* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002885 | PPR_rpt | Repeat |
| IPR011990 | TPR-like_helical_dom_sf | Homologous_superfamily |
| IPR019266 | Ribosomal_mS27 | Family |
| IPR034913 | mS27/PTCD2 | Family |
Pfam: PF10037
UniProt features (27 total): helix 19, repeat 2, transit peptide 1, chain 1, strand 1, coiled-coil region 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
77 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8CSS | ELECTRON MICROSCOPY | 2.36 |
| 7P2E | ELECTRON MICROSCOPY | 2.4 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 9OJM | ELECTRON MICROSCOPY | 2.5 |
| 8CSQ | ELECTRON MICROSCOPY | 2.54 |
| 8CSR | ELECTRON MICROSCOPY | 2.54 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 8CSP | ELECTRON MICROSCOPY | 2.66 |
| 7PNX | ELECTRON MICROSCOPY | 2.76 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 8CST | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 7PO0 | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 7PO1 | ELECTRON MICROSCOPY | 2.92 |
| 7PO3 | ELECTRON MICROSCOPY | 2.92 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6RW4 | ELECTRON MICROSCOPY | 2.97 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
| 8QRN | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | ELECTRON MICROSCOPY | 2.98 |
| 8OIS | ELECTRON MICROSCOPY | 3 |
| 9G5C | ELECTRON MICROSCOPY | 3 |
| 9G5D | ELECTRON MICROSCOPY | 3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q92552-F1 | 80.81 | 0.38 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 145 (showing top):
MORF_DNMT1, GOBP_MITOCHONDRIAL_TRANSLATION, MORF_HDAC2, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, MORF_BUB3, MORF_RFC4, MORF_PRKDC, GOCC_MITOCHONDRIAL_ENVELOPE, ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN, SCHLOSSER_SERUM_RESPONSE_DN, CAIRO_HEPATOBLASTOMA_UP, JAATINEN_HEMATOPOIETIC_STEM_CELL_UP, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, CUI_TCF21_TARGETS_2_UP
GO Biological Process (3): regulation of translation (GO:0006417), cell population proliferation (GO:0008283), mitochondrial translation (GO:0032543)
GO Molecular Function (4): tRNA binding (GO:0000049), rRNA binding (GO:0019843), RNA binding (GO:0003723), protein binding (GO:0005515)
GO Cellular Component (7): nucleolus (GO:0005730), cytoplasm (GO:0005737), mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial small ribosomal subunit (GO:0005763), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| translation | 2 |
| RNA binding | 2 |
| intracellular membraneless organelle | 2 |
| post-transcriptional regulation of gene expression | 1 |
| regulation of protein metabolic process | 1 |
| cellular process | 1 |
| mitochondrion | 1 |
| mitochondrial gene expression | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar small ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
1466 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPS27 | MRPS10 | P82664 | 724 |
| MRPS27 | DAP3 | P51398 | 709 |
| MRPS27 | MRPS30 | Q9NP92 | 690 |
| MRPS27 | MRPS2 | Q9Y399 | 654 |
| MRPS27 | MRPS5 | P82675 | 652 |
| MRPS27 | PTCD1 | O75127 | 632 |
| MRPS27 | MRPS14 | O60783 | 632 |
| MRPS27 | PTCD3 | Q96EY7 | 623 |
| MRPS27 | MRPS25 | P82663 | 614 |
| MRPS27 | MRPL38 | Q96DV4 | 608 |
| MRPS27 | MRPS18B | Q9Y676 | 605 |
| MRPS27 | MRPL11 | Q9Y3B7 | 601 |
| MRPS27 | PTCD2 | Q8WV60 | 595 |
| MRPS27 | MRPL44 | Q9H9J2 | 591 |
| MRPS27 | MRPL58 | Q14197 | 591 |
IntAct
222 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FBL | NOP56 | psi-mi:“MI:0914”(association) | 0.800 |
| MRPS18B | MRPS27 | psi-mi:“MI:0915”(physical association) | 0.770 |
| YBX1 | HNRNPR | psi-mi:“MI:0914”(association) | 0.770 |
| MRPS27 | MRPS15 | psi-mi:“MI:0915”(physical association) | 0.740 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| rep | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.660 |
| MRPS27 | MRPS14 | psi-mi:“MI:0914”(association) | 0.640 |
| ESR1 | TRIM24 | psi-mi:“MI:0914”(association) | 0.640 |
| IGF2BP1 | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.640 |
| LIN28A | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.640 |
| MRPS6 | STAT5A | psi-mi:“MI:0914”(association) | 0.550 |
| RPS6 | IPO7 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS24 | ZZEF1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS15 | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| TRMT10B | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| DAP3 | PNMA6A | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS18B | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS34 | ZZEF1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS18C | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| PDGFB | DKC1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS15 | PRKACG | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS27 | YBX1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL18 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS34 | MRPS12 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (492): NECAB2 (Two-hybrid), MRPS27 (Affinity Capture-RNA), MRPS27 (Affinity Capture-RNA), MRPS27 (Affinity Capture-MS), MRPS27 (Affinity Capture-MS), MRPS27 (Affinity Capture-MS), MRPS27 (Affinity Capture-MS), MRPS27 (Affinity Capture-MS), MRPS27 (Affinity Capture-MS), RPS8 (Affinity Capture-MS), DNAJC1 (Affinity Capture-MS), LRRC15 (Affinity Capture-MS), MRPS27 (Affinity Capture-MS), MRPS27 (Affinity Capture-MS), MRPS27 (Affinity Capture-MS)
ESM2 similar proteins: A1A5P5, A1L2L5, A1Z9A8, B5DF07, O15091, P42704, Q07DV3, Q08CK1, Q0IHP3, Q14C51, Q14CX7, Q14CZ7, Q28C74, Q28DE0, Q2KI62, Q32LU7, Q32N55, Q32PI8, Q3SZ55, Q4R366, Q4R6I5, Q53R41, Q566X6, Q58CX2, Q5R503, Q5R8W8, Q5RFI6, Q5SGE0, Q5XIR8, Q5ZKK3, Q5ZLS8, Q68FN9, Q6AYP3, Q6DI86, Q6GQ66, Q6PB66, Q6QI44, Q7L8L6, Q7TMV3, Q7Z3E5
Diamond homologs: Q32PI8, Q8BK72, Q92552
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPS27 | “form complex” | “28S mitochondrial small ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 223 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial translation | 26 | 25.0× | 6e-28 |
| Mitochondrial translation initiation | 28 | 24.9× | 1e-29 |
| Mitochondrial translation elongation | 28 | 24.9× | 1e-29 |
| Mitochondrial ribosome-associated quality control | 28 | 24.0× | 2e-29 |
| Mitochondrial translation termination | 28 | 21.5× | 5e-28 |
| Translation | 32 | 13.9× | 6e-26 |
| Eukaryotic Translation Initiation | 5 | 10.8× | 3e-03 |
| Cap-dependent Translation Initiation | 5 | 10.8× | 3e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 30 | 25.8× | 2e-31 |
| translation | 21 | 10.7× | 4e-13 |
| ribosomal small subunit biogenesis | 9 | 10.2× | 1e-04 |
| negative regulation of translation | 9 | 8.7× | 3e-04 |
| cytoplasmic translation | 8 | 7.3× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
82 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 59 |
| Likely benign | 5 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2368 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:72221743:C:A | donor_gain | 1.0000 |
| 5:72223678:TTCA:T | donor_loss | 1.0000 |
| 5:72223679:TCACC:T | donor_loss | 1.0000 |
| 5:72223680:CA:C | donor_loss | 1.0000 |
| 5:72223681:A:T | donor_loss | 1.0000 |
| 5:72223682:C:CA | donor_loss | 1.0000 |
| 5:72223693:T:A | donor_gain | 1.0000 |
| 5:72223846:TCGAG:T | acceptor_gain | 1.0000 |
| 5:72223847:CGAG:C | acceptor_gain | 1.0000 |
| 5:72223847:CGAGC:C | acceptor_gain | 1.0000 |
| 5:72226032:ACTG:A | donor_gain | 1.0000 |
| 5:72226033:CTGC:C | donor_gain | 1.0000 |
| 5:72226055:A:AC | donor_gain | 1.0000 |
| 5:72226056:C:CC | donor_gain | 1.0000 |
| 5:72226056:CCG:C | donor_gain | 1.0000 |
| 5:72226071:G:C | donor_gain | 1.0000 |
| 5:72232442:CA:C | donor_gain | 1.0000 |
| 5:72232569:A:AC | acceptor_gain | 1.0000 |
| 5:72232569:A:C | acceptor_gain | 1.0000 |
| 5:72234113:TCTTA:T | donor_loss | 1.0000 |
| 5:72234114:CTTA:C | donor_loss | 1.0000 |
| 5:72234115:TTAC:T | donor_loss | 1.0000 |
| 5:72234116:TA:T | donor_loss | 1.0000 |
| 5:72234118:C:CG | donor_loss | 1.0000 |
| 5:72234195:AACCT:A | acceptor_loss | 1.0000 |
| 5:72234198:CTATA:C | acceptor_loss | 1.0000 |
| 5:72238009:CTCA:C | donor_loss | 1.0000 |
| 5:72238010:TCA:T | donor_loss | 1.0000 |
| 5:72238011:CACCT:C | donor_loss | 1.0000 |
| 5:72238012:A:AT | donor_loss | 1.0000 |
AlphaMissense
2699 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:72238076:A:G | W112R | 0.995 |
| 5:72238076:A:T | W112R | 0.995 |
| 5:72228294:A:C | S222R | 0.991 |
| 5:72228294:A:T | S222R | 0.991 |
| 5:72228296:T:G | S222R | 0.991 |
| 5:72238064:A:G | C116R | 0.988 |
| 5:72238125:A:C | F95L | 0.987 |
| 5:72238125:A:T | F95L | 0.987 |
| 5:72238127:A:G | F95L | 0.987 |
| 5:72297654:A:T | V67D | 0.987 |
| 5:72238116:G:C | S98R | 0.985 |
| 5:72238116:G:T | S98R | 0.985 |
| 5:72238118:T:G | S98R | 0.985 |
| 5:72228280:C:T | G227D | 0.984 |
| 5:72238123:C:G | R96P | 0.984 |
| 5:72228346:C:T | G205D | 0.983 |
| 5:72234159:A:C | N145K | 0.983 |
| 5:72234159:A:T | N145K | 0.983 |
| 5:72234154:A:G | L147P | 0.982 |
| 5:72228337:A:G | L208P | 0.981 |
| 5:72238091:A:G | W107R | 0.981 |
| 5:72238091:A:T | W107R | 0.981 |
| 5:72238036:G:T | A125D | 0.980 |
| 5:72238062:A:C | C116W | 0.980 |
| 5:72297650:A:C | S68R | 0.980 |
| 5:72297650:A:T | S68R | 0.980 |
| 5:72297652:T:G | S68R | 0.980 |
| 5:72295537:A:G | L92P | 0.975 |
| 5:72314112:C:A | W40C | 0.973 |
| 5:72314112:C:G | W40C | 0.973 |
dbSNP variants (sampled 300 via entrez): RS1000000986 (5:72236465 G>A), RS1000043765 (5:72226883 G>A,T), RS1000078953 (5:72285818 C>T), RS1000080388 (5:72277985 T>C), RS1000105528 (5:72235519 G>A), RS1000145706 (5:72272989 A>G), RS1000157582 (5:72242468 A>C,T), RS1000181315 (5:72245061 G>T), RS1000201124 (5:72263022 T>G), RS1000236339 (5:72284886 T>C), RS1000253776 (5:72234040 G>A,C,T), RS1000259274 (5:72279548 G>A,C), RS1000273362 (5:72242033 T>G), RS1000291004 (5:72242478 C>G), RS1000338044 (5:72248797 A>G)
Disease associations
OMIM: gene MIM:611989 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_30 | Refractive error | 1.000000e-12 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066440 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
4 potent at pChembl≥5 of 4 total, top 4 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 7.00 | Kd | 99.01 | nM | CHEMBL3752910 |
| 7.00 | ED50 | 99.01 | nM | CHEMBL3752910 |
| 6.08 | Kd | 835.1 | nM | CHEMBL5653589 |
| 6.08 | ED50 | 835.1 | nM | CHEMBL5653589 |
PubChem BioAssay actives
2 with measured affinity, of 4 total; 2 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2148779: Binding affinity to human MRPS27 incubated for 45 mins by Kinobead based pull down assay | kd | 0.0990 | uM |
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2148779: Binding affinity to human MRPS27 incubated for 45 mins by Kinobead based pull down assay | kd | 0.8351 | uM |
CTD chemical–gene interactions
41 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | affects cotreatment, decreases expression | 3 |
| Ozone | affects cotreatment, increases oxidation, increases abundance, affects expression | 3 |
| methacrylaldehyde | affects cotreatment, increases oxidation, increases abundance | 2 |
| Acrolein | affects cotreatment, increases oxidation, increases abundance | 2 |
| Air Pollutants | affects expression, affects cotreatment, increases abundance, increases oxidation | 2 |
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| alpha-pinene | affects cotreatment, increases oxidation, increases abundance | 1 |
| bisphenol A | decreases expression | 1 |
| lead acetate | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| 2,3-bis(3’-hydroxybenzyl)butyrolactone | increases expression, affects cotreatment | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| LDN 193189 | affects cotreatment, decreases expression | 1 |
| bisphenol AF | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Cisplatin | affects response to substance | 1 |
| Coumestrol | affects cotreatment, increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Endosulfan | decreases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Estradiol | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5651821 | Binding | Binding affinity to human MRPS27 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.